Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

por Piovesan, Dana, Tan, Joanne B.L., Becker, Annette, Banuelos, Jesus, Narasappa, Nell, DiRenzo, Daniel, Zhang, Kristen, Chen, Ada, Ginn, Elaine, Udyavar, Akshata R., Yin, Fangfang, Paprcka, Susan L., Purandare, Bhamini, Park, Timothy W., Kimura, Nikki, Kalisiak, Jaroslaw, Young, Stephen W., Powers, Jay P., Schindler, Uli, Sivick, Kelsey E., Walters, Matthew J.
Publicado 2022

A novel luciferase-based assay for the detection of Chimeric Antigen Receptors

por Gopalakrishnan, Ramakrishnan, Matta, Hittu, Choi, Sunju, Natarajan, Venkatesh, Prins, Ruben, Gong, Songjie, Zenunovic, Arta, Narasappa, Nell, Patel, Fatima, Prakash, Rekha, Chaudhary, Vishan, Sikri, Varun, Chitnis, Saurabh Deepak, Kochegarov, Andrei, Wang, Dan, Falat, Magdalena, Kahn, Michael, Keerthipati, Pooja Smruthi, Sharma, Naman, Lenka, Jyotirmayee, Stieben, Tomas Meza, Braun, Jason, Batra, Ankita, Purvis, Katelyn, Ito, Kenta, Lee, Jae Han, Jeronimo, Alberto, Zamora, Hannalei Mae, Membreno, Allen, Qiu, Queenie, Peshin, Supriya, Namburu, Lalith, Chaudhary, Preet M.
Publicado 2019